TNM cancer staging: can it help develop a novel staging system for type 2 diabetes?
Moahad S Dar,1,2 Sami A Bég3 1Department of Veteran Affairs, Greenville Health Care Center, Greenville, NC, USA; 2Division of Endocrinology & Metabolism, Department of Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, NC, USA; 3Proactive Living I...
Enregistré dans:
Auteurs principaux: | Dar MS, Bég SA |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/84f3a2ee9dde4d4e8aa6c2d1866341f7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
par: Kalra S, et autres
Publié: (2021) -
Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
par: Hu Y, et autres
Publié: (2021) -
Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis
par: Mahboobeh sadat Hosseini, MD, et autres
Publié: (2021) -
Platelet Indices and Its Association with Microvascular Complications Among Type 2 Diabetes Mellitus Patients in Northeast Ethiopia: A Cross-Sectional Study
par: Taderegew MM, et autres
Publié: (2021) -
Second line therapy in type 2 diabetes: legacy effect activation
par: Ekaterina A. Shestakova
Publié: (2017)